This paper is in the following e-collection/theme issue:

Non-Randomized Study Protocols and Methods (Non-eHealth) (574) Obstetrics, Gynecology, and Reproductive Medicine (226)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/48854, first published .
Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study

Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study

Validation of an Anti-Müllerian Hormone Cutoff for Polycystic Ovarian Morphology in the Diagnosis of Polycystic Ovary Syndrome in the HARMONIA Study: Protocol for a Prospective, Noninterventional Study

Authors of this article:

Terhi T Piltonen1, 2 Author Orcid Image ;   Deirdre Allegranza3 Author Orcid Image ;   Martin Hund3 Author Orcid Image ;   Katharina Buck4 Author Orcid Image ;   Johanna Sillman3 Author Orcid Image ;   Riikka K Arffman1, 2 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Journals

  1. Piltonen T, Viita-aho J, Saarela U, Melin J, Forslund M. Utility of Serum Anti-Müllerian Hormone Measurement as Part of Polycystic Ovary Syndrome Diagnosis. Seminars in Reproductive Medicine 2024;42(01):049 View
  2. Madikyzy M, Durmanova A, Trofimov A, Akbay B, Tokay T. Evaluation of Biochemical Serum Markers for the Diagnosis of Polycystic Ovary Syndrome (PCOS) in Obese Women in Kazakhstan: Is Anti-Müllerian Hormone a Potential Marker?. Biomedicines 2024;12(10):2333 View